Advances
in molecular biology allow surgically-removed
tumor tissue to be processed and
stored in a living condition indefinitely.
Cryopreserved tumor tissue remains
available to use in accessing current
and future treatment options as
needed.
BENEFITS
The tissue
may be the important source of vital
treatment information.....currently.
It
allows positioning to utilize an ever-increasing
range of treatment options.....in the
future:
TDAC or other activated
cell technologies
Chemosensitivity
assays
Hormone
receptor assays
Monoclonal antibodies
Tumor cell vaccines
Genetic analysis
Flow cytometry
It
can provide a head start on growing
TDAC or cells for vaccines to pursue
these as future treatment options...
and without another surgery to obtain
additional tumor tissue.
Reduces
the physician's and hospital's potential
liability regarding discarding the
tumor and not having tissue available
to explore additional treatment options.
Creates
a competitive advantage for the hospital
by providing local access to the CryoBank
program.
ELIGIBILITY CRITERIA
All malignant
tumors should be considered for Cryopreservation
except those from patients whose physical
condition and medical complications,
in the opinion of the attending physician,
indicate that future use of cell-related
therapies is unlikely. In addition,
tumors of the brain and other neurological
tissues have not shown measurable benefits
from cell-related therapies.
TUMOR PREPARATION AND TRANSPORT
Recognizing that
eligible surgeries often are scheduled
at the last minute, we can provide fully
prepared Tumor Transport Kits within
24 hours. As a normal routine, for physicians
and hospitals, we will assist by keeping
an adequate number of kits on hand by
automatically sending back a replacement
kit each time we receive a tumor for
processing.
BILLING
Service
Research
Service Charge
Cryopreservation
and Processing
$1,250
Cancer
Therapeutics, Inc.™ (CTI)
is a leader in activated cell technology
offering cell cryopreservation (CryoBank)
services.
